SCHEMBL23965369

SCHEMBL23965369

c1ccc2c(c1)Sc1ccccc1C21c2ccccc2-c2c(-c3ccc(-c4nc(-c5ccc6ccccc6c5)nc(-c5ccc6ccccc6c5)n4)cc3)cccc21

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC4 P56524 1/20 0.33
HDAC2 Q92769 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
CYP1A2 P05177 4/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
ALDH1A1 P00352 3/20 0.32
KDM4E B2RXH2 2/20 0.32
MEN1 O00255 1/20 0.32
TP53 P04637 1/20 0.32
KMT2A Q03164 1/20 0.32
HSD17B10 Q99714 1/20 0.32
GSTP1 P09211 1/20 0.31
MET P08581 1/20 0.31
SLC6A2 P23975 1/20 0.30
SLC6A4 P31645 1/20 0.30
SLC6A3 Q01959 1/20 0.30
CYP2C9 P11712 1/20 0.30
HPGD P15428 1/20 0.30
CYP2C19 P33261 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23965371 0.98 MEN1 (0.36) HDAC4HDAC2HDAC8CYP1A2SMN1; SMN2
SCHEMBL23965257 0.94 MEN1 (0.35) HDAC4HDAC2HDAC8CYP1A2SMN1; SMN2
SCHEMBL23964987 0.94 HDAC4 (0.33) HDAC4HDAC2HDAC8CYP1A2SMN1; SMN2
SCHEMBL23965373 0.94 PIM1 (0.34) HDAC8SMN1; SMN2ALDH1A1KDM4ETP53
SCHEMBL22100219 0.93 MEN1 (0.36) HDAC4HDAC2HDAC8CYP1A2SMN1; SMN2
SCHEMBL23965324 0.91 KDM4E (0.34) HDAC4HDAC2HDAC8CYP1A2SMN1; SMN2
SCHEMBL17151582 0.90 HDAC4 (0.37) HDAC4HDAC2HDAC8CYP1A2SMN1; SMN2
SCHEMBL23965323 0.90 MEN1 (0.35) HDAC4HDAC2HDAC8CYP1A2SMN1; SMN2
SCHEMBL21477970 0.89 CYP1A1 (0.44) CYP1A2SMN1; SMN2ALDH1A1KDM4EMEN1
SCHEMBL21151247 0.89 ADORA3 (0.35) SMN1; SMN2ALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME LG CHEM, LTD. (KR) 2021-10-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210336155-A1 CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING SAME CCNL2, MCM6, CRY1 HDAC4 2948/4885HDAC2 1145/4885HDAC8 3664/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.